Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qiagen NVMIL:1QGEN +0.30%53 3-1 Month Momentum % is 14.42% as of Sep. 09, 2026. GuruFocus rates MIL:1QGEN with a GF Score™ of 53/100 and a GF Value™ of €41.30 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 210 Medical Diagnostics & Research companies, Qiagen NV ranks better than 72.38% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-09), Qiagen NV's 3-1 Month Momentum % is 14.42%.
The industry rank for Qiagen NV's 3-1 Month Momentum % or its related term are showing as below:
MIL:1QGEN's 3-1 Month Momentum % is ranked better than 72.38% of 210
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.78
vs MIL:1QGEN: 14.42
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Qiagen NV 3-1 Month Momentum % Related Terms
MIL:1QGEN vs TWST, RDNT, SHC: 3-1 Month Momentum % Comparison
For the Diagnostics & Research subindustry, Qiagen NV's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qiagen NV 3-1 Month Momentum % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Qiagen NV's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qiagen NV (MIL:1QGEN) has a 3-1 Month Momentum % of 14.42% as of Sep. 09, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Qiagen NV and its competitors. According to the industry distribution chart, Qiagen NV ranks #58 out of 210 companies in the Medical Diagnostics & Research industry, placing it in the top 27.6%.
Is Qiagen NV's 3-1 Month Momentum % too high?
Qiagen NV's current 3-1 Month Momentum % is 14.42%. The Medical Diagnostics & Research industry median 3-1 Month Momentum % is 0.78. Qiagen NV's value of 14.42% is 1748.7% above this industry median. Based on the distribution chart, Qiagen NV ranks #58 out of 210 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Qiagen NV has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qiagen NV's 3-1 Month Momentum % compare to TWST and RDNT?
According to the Medical Diagnostics & Research industry distribution chart, Qiagen NV ranks #58 out of 210 companies for 3-1 Month Momentum %. This puts Qiagen NV in the upper half of its industry. The industry median 3-1 Month Momentum % is 0.78. Qiagen NV's value of 14.42% is 1748.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Diagnostics & Research company?
The median 3-1 Month Momentum % among Medical Diagnostics & Research companies is 0.78, based on 210 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qiagen NV's current 3-1 Month Momentum % of 14.42% is 1748.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Qiagen NV and its competitors. For the Medical Diagnostics & Research industry, the median 3-1 Month Momentum % is 0.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qiagen NV's current 3-1 Month Momentum % is 14.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qiagen NV stock overvalued right now?
Based on GuruFocus' analysis, Qiagen NV (MIL:1QGEN) is currently considered Modestly Undervalued. The stock's GF Value™ is €41.30, compared to a current price of €36.48 — trading 11.7% below its estimated fair value. The current 3-1 Month Momentum % is 14.42% and 1748.7% above the Medical Diagnostics & Research industry median of 0.78. Qiagen NV's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Qiagen NV (MIL:1QGEN), the current 3-1 Month Momentum % is 14.42% as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qiagen NV (MIL:1QGEN) Overvalued in 2026?
Based on GuruFocus' analysis, Qiagen NV stock appears to be undervalued.
The current stock price of €36.48 is trading 11.7% below its estimated GF Value™ of €41.30.
GuruFocus considers Qiagen NV to be Modestly Undervalued.
Key valuation signals for MIL:1QGEN:
3-1 Month Momentum %: 14.42%
GF Value™: €41.30 vs. price of €36.48 (11.7% below fair value)
Industry Position: 1748.7% above the Medical Diagnostics & Research median (#58 of 210)
No single metric tells the full story. See the MIL:1QGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
53GF Score
Get the complete analysis for MIL:1QGEN
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1QGEN has been successfully added to your 
